Lee's Pharmaceutical Holdings Limited

SEHK:950 株式レポート

時価総額:HK$718.4m

Lee's Pharmaceutical Holdings マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間10.1yrs
取締役会の平均在任期間2.8yrs

経営陣の近況

Recent updates

Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem

Sep 04
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem

There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price

Aug 07
There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price

Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

May 21
Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Dec 20
Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

May 21
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Apr 02
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Aug 29
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Apr 05
Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Mar 17
Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

Feb 22
Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 29
What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Jan 12
What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

CEO(最高経営責任者

Lee's Pharmaceutical Holdings CEOがいない、あるいは彼らに関するデータがない。


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Siu Fong Lee
Chairman & Compliance Officerno dataHK$12.18m0.14%
HK$ 976.0k
Xiaoyi Li
Founder3.6yrsHK$6.54m9.99%
HK$ 71.8m
Wanee Leelalertsuphakun
MD, Chief Marketing & Sales Officer and Executive Director21.2yrsHK$13.20m1.43%
HK$ 10.3m
Yiu Ming Chow
Group CFO & Company Secretary10.1yrsデータなしデータなし
Yueshen Chen
Director of Administration in Chinano dataデータなしデータなし
Tsui Victor Kailok
Group Chief Manufacturing Officer12.8yrsデータなしデータなし
Yuanjue Sun
Chief Medical Officer3.2yrsデータなしデータなし
Zhongyu Jiao
Group Deputy GM & GM of the Risk Control Centreno dataデータなしデータなし

10.1yrs

平均在職期間

61yo

平均年齢

経験豊富な経営陣: 950の経営陣は経験豊富で経験豊富です(平均在職期間は10.1年)。


取締役

名称ポジション在職期間報酬所有権
Siu Fong Lee
Chairman & Compliance Officerno dataHK$12.18m0.14%
HK$ 976.0k
Xiaoyi Li
Founderno dataHK$6.54m9.99%
HK$ 71.8m
Wanee Leelalertsuphakun
MD, Chief Marketing & Sales Officer and Executive Directorno dataHK$13.20m1.43%
HK$ 10.3m
Zuie-Chin Huang
Non-Executive Directorless than a yearデータなし0.085%
HK$ 610.0k
James Gale
Non-Executive Director2.8yrsHK$300.00kデータなし
Yau Ching Chan
Independent Non-Executive Director22.8yrsHK$216.00k0.088%
HK$ 634.4k
Wah Keung Tsim
Independent Non-Executive Director20.2yrsHK$216.00k0.051%
HK$ 366.0k
Yee Wah Cheang
Independent Non Executive Director1.5yrsHK$135.00kデータなし

2.8yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: 950の 取締役会経験豊富 ではない ( 2.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。